Fresenius Medical Care AG & Co. (Pref) (ETR:FME) has been assigned a €83.00 ($97.65) price objective by research analysts at Deutsche Bank AG in a report released on Friday. The firm currently has a “neutral” rating on the stock. Deutsche Bank AG’s target price would indicate a potential upside of 0.67% from the company’s current price.

Several other research firms also recently issued reports on FME. Independent Research GmbH set a €88.00 ($103.53) price target on shares of Fresenius Medical Care AG & Co. (Pref) and gave the company a “neutral” rating in a research note on Wednesday, August 2nd. Jefferies Group LLC set a €83.00 ($97.65) price target on shares of Fresenius Medical Care AG & Co. (Pref) and gave the company a “neutral” rating in a research note on Wednesday, August 2nd. J P Morgan Chase & Co set a €106.40 ($125.18) price target on shares of Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a research note on Wednesday, August 2nd. Goldman Sachs Group, Inc. (The) set a €98.00 ($115.29) price target on shares of Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a research note on Wednesday, August 2nd. Finally, S&P Global set a €95.00 ($111.76) price target on shares of Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a research note on Tuesday, August 1st. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and nine have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of €89.12 ($104.84).

COPYRIGHT VIOLATION NOTICE: This news story was published by American Banking News and is the property of of American Banking News. If you are viewing this news story on another website, it was illegally copied and republished in violation of U.S. & international copyright & trademark laws. The original version of this news story can be read at https://www.americanbankingnews.com/2017/11/03/fresenius-medical-care-ag-83-00-by-deutsche-bank-ag-2.html.

About Fresenius Medical Care AG & Co. (Pref)

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. (Pref) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. (Pref) and related companies with MarketBeat.com's FREE daily email newsletter.